E-LIB Suche - Ergebnisse für: Ito, Sae

1

High‐throughput system for the thermostability analysis of ..:

Ito, Sae ; Matsunaga, Ryo ; Nakakido, Makoto...
Protein Science. 33 (2024) 6 - p. , 2024

Link: https://doi.org/10.1002/..

2

Physiologically based pharmacokinetic model analysis of the..:

Okubo, Kenjiro ; Kudo, Toshiyuki ; Yoshihara, Sae...
Drug Metabolism and Pharmacokinetics. 54 (2024) - p. 100537 , 2024

Link: https://doi.org/10.1016/..

3

Dimension dependence of current injection path in GaInN/GaN..:

Katsuro, Sae ; Lu, Weifang ; Ito, Kazuma...
Nanophotonics. 12 (2023) 15 - p. 3077-3087 , 2023

Link: https://doi.org/10.1515/..

4

Analysis of HepG2 cell response to a wide concentration ran..:

Muramatsu, Hiroshi ; Naka, Masahiro ; Ito, Sae.
Heliyon. 9 (2023) 9 - p. e20047 , 2023

Link: https://doi.org/10.1016/..

5

Identification and characterization of endo-α-, exo-α-, and..:

Shimokawa, Michiko ; Ishiwata, Akihiro ; Kashima, Toma...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

6

Author Correction: Identification and characterization of e..:

Shimokawa, Michiko ; Ishiwata, Akihiro ; Kashima, Toma...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

7

Health outcomes of the G7 Hiroshima Summit: breaking the cy..:

Ezoe, Satoshi ; Hashimoto, Jin ; Nishida, Yuichiro...
The Lancet. 401 (2023) 10394 - p. 2091-2093 , 2023

Link: https://doi.org/10.1016/..

8

Prevalence of pathogenic variants in cancer‐predisposing ge..:

Yoshida, Masanori ; Nakabayashi, Kazuhiko ; Yang, Wentao...
Cancer Medicine. 12 (2023) 10 - p. 11264-11273 , 2023

Link: https://doi.org/10.1002/..

9

Determination of a Serum 25-Hydroxyvitamin D Reference Rang..:

Miyamoto, Hiroyasu ; Kawakami, Daisuke ; Hanafusa, Nobuhiro...
The Journal of Nutrition. 153 (2023) 4 - p. 1253-1264 , 2023

Link: https://doi.org/10.1016/..

10

Prevalence of pathogenic variants in cancer‐predisposing ge..:

Masanori Yoshida ; Kazuhiko Nakabayashi ; Wentao Yang...
https://doi.org/10.1002/cam4.5835. , 2023

Link: https://doi.org/10.1002/..

11

Identification and characterization of endo-α-, exo-α-, and..:

Shimokawa, Michiko ; Ishiwata, Akihiro ; Kashima, Toma...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509167/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Identification and characterization of endo-α-, exo-α-, and..:

Michiko Shimokawa ; Akihiro Ishiwata ; Toma Kashima...
https://doi.org/10.1038/s41467-023-41431-2. , 2023

Link: https://doi.org/10.1038/..

13

Author Correction: Identification and characterization of e..:

Michiko Shimokawa ; Akihiro Ishiwata ; Toma Kashima...
https://doi.org/10.1038/s41467-023-42065-0. , 2023

Link: https://doi.org/10.1038/..

14

Hyperprogressive disease during atezolizumab plus bevacizum..:

Yumita, Sae ; Ogasawara, Sadahisa ; Nakagawa, Miyuki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067175/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Hyperprogressive disease during atezolizumab plus bevacizum..:

Sae Yumita ; Sadahisa Ogasawara ; Miyuki Nakagawa...
https://doi.org/10.1186/s12876-023-02731-5. , 2023

Link: https://doi.org/10.1186/..